Journal articleLancet2016

Gemcitabine-resistant pancreatic cancer: a second-line option.

DOI 10.1016/s0140-6736(15)01035-1 ↗ OpenAlex, retrieved 5 November 2026

Journal: Lancet
Published: 23 November 2015
Citations: 11
Type: Article

These are bibliographic fields. A study card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try